We are live on !
Find out more
Marshall & Sullivan Portfolio holdings
AUM
$216M
Turnover
63.87%
1-Year Est. Return
12.97%
This Fund
S&P 500
This Quarter Est. Return
+1.59%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+99.76%
10 Year Est. Return
+295.36%
AUM
$77.6M
AUM Growth
-$1.01M
(-1.3%)
Cap. Flow
-$1.22M
Cap. Flow % of AUM
Cap. Flow %
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
45.21%
Holding
65
New
1
Increased
2
Reduced
32
Closed
9
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNC
Spectranetics Corp
SPNC
|
+$17.6K |
| 2 |
Stericycle Inc
SRCL
|
+$8.24K |
| 3 |
Apple
AAPL
|
+$5.96K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$328K |
| 2 |
Starbucks
SBUX
|
+$114K |
| 3 |
Danaher
DHR
|
+$53.4K |
| 4 |
Stryker
SYK
|
+$49.2K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$49K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.84% |
| 2 | Consumer Staples | 18.06% |
| 3 | Technology | 16.39% |
| 4 | Consumer Discretionary | 12.74% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Fiserv Inc
FISV
$26.6B
| $4.24M | 5.47% |
78,078
-538
| -0.7% | -$27.7K |
2013 Q2
12 quarters
|
|
2
Church & Dwight Co
CHD
$25.3B
| $3.89M | 5.02% |
75,688
-674
| -0.9% | -$32.5K |
2013 Q2
12 quarters
|
|
|
3
Stryker
SYK
$112B
| $3.69M | 4.76% |
30,817
-440
| -1% | -$49.2K |
2013 Q2
12 quarters
|
|
4
Becton Dickinson
BDX
$53.9B
| $3.46M | 4.46% |
20,947
-197
| -0.9% | -$31.5K |
2013 Q2
12 quarters
|
|
5
Home Depot
HD
$328B
| $3.45M | 4.44% |
27,001
-341
| -1% | -$45.1K |
2013 Q3
11 quarters
|
|
|
6
Danaher
DHR
$163B
| $3.43M | 4.42% |
50,534
-817
| -2% | -$53.4K |
2013 Q2
12 quarters
|
|
7
DELISTED
Walgreens Boots Alliance
WBA
| $3.37M | 4.34% |
40,425
-84
| -0.2% | -$6.78K |
2013 Q2
12 quarters
|
|
8
Johnson & Johnson
JNJ
$658B
| $3.36M | 4.33% |
27,706
-309
| -1% | -$35.1K |
2013 Q2
12 quarters
|
|
|
9
Apple
AAPL
$5.03T
| $3.12M | 4.02% |
130,432
+240
| +0.2% | +$5.96K |
2013 Q2
12 quarters
|
|
10
PepsiCo
PEP
$187B
| $3.07M | 3.96% |
29,007
-123
| -0.4% | -$12.7K |
2013 Q2
12 quarters
|
|
11
Colgate-Palmolive
CL
$75.7B
| $3.02M | 3.89% |
41,224
-403
| -1% | -$28.7K |
2013 Q2
12 quarters
|
|
12
Cognizant
CTSH
$29.1B
| $2.9M | 3.74% |
50,727
-215
| -0.4% | -$13K |
2013 Q2
12 quarters
|
|
|
ESRX
13
DELISTED
Express Scripts Holding Company
ESRX
| $2.76M | 3.56% |
36,429
-16
| -0% | -$1.18K |
2013 Q2
12 quarters
|
|
14
Crown Holdings
CCK
$12.9B
| $2.75M | 3.55% |
54,355
-316
| -0.6% | -$16.5K |
2013 Q2
12 quarters
|
|
15
RTX Corp
RTX
$270B
| $2.7M | 3.49% |
41,918
-500
| -1% | -$32K |
2013 Q2
12 quarters
|
|
16
Emerson Electric
EMR
$92B
| $2.5M | 3.22% |
47,946
-462
| -1% | -$24.5K |
2013 Q2
12 quarters
|
|
17
Alphabet (Google) Class A
GOOGL
$3.44T
| $2.5M | 3.22% |
70,980
-660
| -0.9% | -$24.2K |
2015 Q3
3 quarters
|
|
18
DELISTED
Praxair Inc
PX
| $2.47M | 3.19% |
22,002
-181
| -0.8% | -$20.5K |
2013 Q2
12 quarters
|
|
19
Monster Beverage
MNST
$92.7B
| $2.16M | 2.78% |
161,064
-2,448
| -1% | -$29.5K |
2013 Q2
12 quarters
|
|
20
Thermo Fisher Scientific
TMO
$258B
| $2M | 2.58% |
13,537
-316
| -2% | -$46.6K |
2013 Q2
12 quarters
|
|
21
Booking.com
BKNG
$111B
| $1.76M | 2.27% |
35,275
-350
| -1% | -$18.2K |
2013 Q2
12 quarters
|
|
22
Mastercard
MA
$556B
| $1.69M | 2.18% |
19,236
-183
| -0.9% | -$17.5K |
2013 Q2
12 quarters
|
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $1.54M | 1.98% |
15,598
-64
| -0.4% | -$6.62K |
2013 Q2
12 quarters
|
|
|
WWAV
24
DELISTED
The WhiteWave Foods Company
WWAV
| $1.53M | 1.98% |
32,699
-453
| -1% | -$19.5K |
2016 Q1
1 quarter
|
|
25
Gilead Sciences
GILD
$212B
| $1.49M | 1.92% |
17,883
-24
| -0.1% | -$2.13K |
2013 Q2
12 quarters
|
|
Similar funds
Marshall & Sullivan's Q2 2016 Portfolio in Review
As of Q2 2016, Marshall & Sullivan held 65 positions worth $77.6M, down 1.3% from $78.6M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Marshall & Sullivan's Q2 2016 filing shows 1 new, 2 increased, 32 reduced and 9 closed positions. Its largest new stake was Spectranetics Corp: 1,000 shares worth $18K. The largest sale was Alphabet (Google) Class C, an estimated $328K.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.
- Marshall & Sullivan's largest Q2 2016 buy was Spectranetics Corp: 1,000 shares worth $18K.
- Marshall & Sullivan added most to Stericycle Inc in Q2 2016, an estimated $8.24K increase.
- Marshall & Sullivan's biggest Q2 2016 reduction was Alphabet (Google) Class C, cutting an estimated $328K.
- Marshall & Sullivan fully exited Regeneron Pharmaceuticals in Q2 2016, selling an estimated $49K.
- Marshall & Sullivan's ten largest holdings make up 45% of its $77.6M portfolio in Q2 2016.
- Marshall & Sullivan opened 1 new position and closed 9 in Q2 2016.
- Marshall & Sullivan's portfolio value fell 1.3% quarter-over-quarter to $77.6M.
Based on Marshall & Sullivan's 13F filing for Q2 2016, filed 12 Aug 2016.